Ignite Creation Date:
2024-05-06 @ 1:39 AM
Last Modification Date:
2024-10-26 @ 11:07 AM
Study NCT ID:
NCT01864746
Status:
COMPLETED
Last Update Posted:
2023-12-12
First Post:
2013-05-14
Brief Title:
A Study of Palbociclib in Addition to Standard Endocrine Treatment in Hormone Receptor Positive Her2 Normal Patients With Residual Disease After Neoadjuvant Chemotherapy and Surgery
Sponsor:
German Breast Group
Organization:
German Breast Group
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-10-30
Start Date Type:
ACTUAL
Primary Completion Date:
2020-08-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-12-21
Completion Date Type:
ACTUAL
First Submit Date:
2013-05-14
First Submit QC Date:
May 24 2013
Study First Post Date:
2013-05-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2023-12-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-22
Last Update Post Date:
2023-12-12
Last Update Post Date Type:
ACTUAL